Somanetics Corporation to Present at UBS Global Life Sciences Conference and Maxim Group Growth Conference

Tuesday, September 11, 2007 General News J E 4
TROY, Mich., Sept. 10 Somanetics Corporation(Nasdaq: SMTS) today announced that management will present an overview of theCompany at the following conferences:

At these conferences, Company management will provide insight aboutSomanetics' business strategy and its recent financial results. Thepresentations will be webcast live. The webcasts may be accessed by visitingthe Investor Relations section of Somanetics' website at presentations also will be archived on Somanetics' website for 30 daysfollowing the conferences.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and marketsthe INVOS(R) Cerebral/Somatic Oximeter System, a non-invasive patientmonitoring system that continuously measures changes in the blood oxygenlevels in the brain and elsewhere in the body in somatic, or skeletal muscle,tissue in patients with or at risk for restricted blood flow. Surgeons,anesthesiologists and other medical professionals can use the informationprovided by the INVOS System, in conjunction with other available information,to identify brain oxygen imbalances and take necessary corrective action,potentially improving patient outcomes and reducing the costs of care.Somanetics supports its customers through a direct U.S. sales force andclinical education team. Tyco Healthcare markets INVOS System products inEurope, Canada, the Middle East and Africa and Edwards Lifesciences representsINVOS System products in Japan. For more information Maxim Group Growth Conference Thursday, September 20, 2007 8:30 a.m. (ET) Grand Hyatt, New York, NY Speaker: William M. Iacona, Somanetics' chief financial officer -- UBS Global Life Sciences Conference Wednesday, September 26, 2007 8:00 a.m. (ET) Grand Hyatt, New York, NY Speaker: Bruce J. Barrett, Somanetics' president and chief executive officer

SOURCE Somanetics Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Kentucky's Home Oxygen Therapy Community Facing $4...
Glass Lewis Recommends Arrow Shareholders Vote on ...